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Summary
Congenital lactase deficiency (CLD) is an autosomal re-
cessive, gastrointestinal disorder characterized bywatery
diarrhea starting during the first 1–10 d of life, in infants
fed lactose-containing milks. Since 1966, 42 patients
have been diagnosed in Finland. CLD is the most severe
form of lactase deficiency, with an almost total lack of
lactase-phlorizin hydrolase (LPH) activity on jejunal bi-
opsy. In adult-type hypolactasia, the most common ge-
netic enzyme deficiency in humans, this enzyme activity
is reduced to 5%–10%. Although the activity of intes-
tinal LPH has been found to be greatly reduced in both
forms, the molecular pathogenesis of lactase deficiencies
is unknown. On the basis of the initial candidate-gene
approach, we assigned the CLD locus to an 8-cM in-
terval on chromosome 2q21 in 19 Finnish families. At
the closest marker locus, a specific allele 2 was present
in 92% of disease alleles. On the basis of a genealogical
study, the CLD mutation was found to be enriched in
sparsely populated eastern and northern Finland, be-
cause of a founder effect. The results of both the ge-
nealogical study and the haplotype analysis indicate that
one major mutation in a novel gene causes CLD in the
Finnish population. Consequently, the critical region
could be restricted further, to an ∼350-kb interval, by
ancient-haplotype and linkage-disequilibrium analyses.
Surprisingly, the LPH gene was shown to lie outside the
critical CLD region, excluding it as a causative gene for
CLD. The LPH locus was found to reside 12 Mb from
the critical CLD region.
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Introduction
Congenital lactase deficiency (CLD; MIM 223000) is a
severe gastrointestinal disorder in newborns that is in-
herited as an autosomal recessive trait. The first patients
were described by Holzel et al. (1959). Thereafter, 16
patients have been described in Finland (Savilahti et al.
1983). To date, a total of 35 CLD families, with 42
patients, have been diagnosed in Finland. The estimated
incidence of CLD is 1:60,000 newborns in the Finnish
population. CLD is considered to belong to the so-called
Finnish disease heritage, together with ∼30 rare, mon-
ogenic disorders enriched in this population because of
a founder effect and genetic drift (Nevanlinna 1972; No-
rio et al. 1973).
CLD is characterized by watery diarrhea starting rap-
idly, within a day of the introduction of lactose-con-
taining infant feed, breast milk, or regular, cow’s milk–
based formulas. The severe diarrhea is caused by un-
absorbed lactose in a high concentration (20–90 g/liter)
and is followed by dehydration, acidosis, and weight
loss, diagnosed at a mean age of 36 d. The lactase activity
in a jejunal biopsy specimen from affected patients is
reduced to 0–10 U/g protein. Jejunal morphology is nor-
mal. On a lactose-free diet the children are free of symp-
toms, and development is normal (Savilahti et al. 1983).
The molecular basis of the nonfunctioning or absent
lactase enzyme has remained unknown.
Owing to the significant decrease of lactase activity in
CLD patients, we focused our initial linkage studies on
chromosome 2q, where the lactase-phlorizin hydrolase
(LPH) gene has been localized (Kruse et al. 1988; Harvey
et al. 1993). In this article, we report assignment of the
CLD gene to the long arm of chromosome 2 in 19 Finn-
ish families. The localization of the CLD gene was re-
fined further by extended haplotype analysis using seven
polymorphic markers on chromosome 2q21, which fa-
cilitated the utilization of ancestral recombinations in
the positioning of the disease locus. An obvious candi-
date, the LPH gene was excluded as a causative gene for
CLD, on the basis of radiation-hybrid (RH) and physical
mapping over the critical CLD region.
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Figure 1 Finnish CLD families studied. Blackened symbols indicate affected individuals. An asterisk (*) indicates that no sample was
available.
Subjects, Material, and Methods
CLD Families and DNA Samples
A total of 27 CLD patients, from 19 families, partici-
pated in the linkage study (fig. 1). The diagnosis of all
patients was based on clinical symptoms. Estimation of
lactase activity in the jejunal biopsy specimen was per-
formed for all but one patient (Savilahti et al. 1983).
DNA was extracted from frozen peripheral blood, in
accordance with standard protocols (Vandenplas et al.
1984). Thirty-one families participated in the genealog-
ical study. Three generations of ancestors were traced,
on the basis of local church registries (Varilo et al.
1996b). Samples were taken in accordance with the Hel-
sinki Declaration.
Analysis of Microsatellite Markers
We analyzed 10 highly polymorphic microsatellite
markers, from the Ge´ne´thon Resource Center, on 2q that
are near the lactase gene (Dib et al. 1996); the genetic
distances are as follows: cen-D2S114-1 cM-D2S1334-
0 cM-D2S2196-0 cM-D2S442-2 cM-D2S314-2 cM-
D2S2385-1 cM-D2S2288-1 cM-D2S397-1 cM-D2S150-
1 cM-D2S132. The order of the markers was obtained
mostly from the physical YAC contig map of chromo-
some 2 (Chumakov et al. 1995), supplemented with data
from the Ge´ne´thon map. PCR was performed in a total
volume of 15 ml containing 12 ng template DNA, 5 pmol
of the primers, 0.2 mM of each nucleotide, 20 mM
TrisHCl (pH 8.8), 15 mM (NH4)2SO4, 1.5 mM MgCl2,
0.1% Tween 20, 0.01% gelatin, and 0.25 U Taq poly-
merase (Dynazyme, Finnzymes). One of the primers was
radiolabeled, at the 5′ end, with g[32P]-ATP. The reac-
tions were performed in a multiwell microtiter plate, for
35 cycles of denaturation at 94C for 30 s, annealing at
various temperatures, depending on the primers, for 30
s, and extension at 72C for 30 s; denaturation was set
at 3 min, and final extension was set at 5 min. The
amplified fragments were separated on 6% polyacryl-
amide gels, and autoradiography was performed.
Linkage and Linkage-Disequilibrium Analyses
Pairwise LOD scores were calculated by use of the
MLINK option of the LINKAGE program package (La-
throp et al. 1984). An autosomal recessive mode of in-
heritance (Nevanlinna 1972; Savilahti et al. 1983) with
100% penetrance and a disease-allele frequency of .001
was assumed. We considered locus heterogeneity to be
highly unlikely, since CLD is one of the rare disorders
enriched in the Finnish population.
Linkage-disequilibrium analyses were performed by
use of the program HRRLAMB (Terwilliger 1995,
1996). This program applies a likelihood-ratio test for
linkage disequilibrium, calculated as parameter l, that
is independent of the number of alleles and, by exten-
sion, of the number of marker loci over a small chro-
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Figure 2 Birthplaces of great-grandparents of 31 CLD families
in Finland. Families with more than one affected child have been
marked only once.
mosomal region. In addition, all genotyping data were
analyzed by use of the HRRMULT program, which is
designed for joint association analysis of multiple loci.
In this method, the recombination fraction between any
given map position and each of the marker loci is fixed,
and the likelihood is maximized, at that map position,
over a (proportion of disease alleles originally associated
with a certain allele) and n (number of generations since
introduction of the founder disease allele into the
population).
RH Mapping
A high-resolution whole genome (TNG) RH panel
(Research Genetics) comprising 90 human-hamster hy-
brid lines was analyzed together with a human lympho-
blastoid cell line (RM; positive control) and nonirra-
diated hamster recipient cells (A3; negative control).
Microsatellites D2S114, AFM338YE5, D2S442,
D2S314, and D2S2385 (Dib et al. 1996) and two primer
sets (from exons 1 and 17; Stanford Human Genome
Center [SHGC] 10723) designed from cDNA of the LPH
gene (Mantei et al. 1988) were amplified, by PCR, from
each RH. PCRs were performed with 15 ng template,
60 pmol of the primers, 200 mM each dNTP, and 0.5 U
Taq polymerase (Dynazyme, Finnzymes) in 50 ml buffer,
under the conditions described above. The PCR products
were visualized on 1.5% agarose gels. The screening
results for the TNG panel were analyzed by use of the
RH server at SHGC. Because of the high-resolution
power of the panel, two markers must be closer together
(∼350 kb from each other) to show linkage; thus, the
mapping results are based on two-point maximum-like-
lihood linkage for the marker screened with the SHGC
G3 map of chromosome 2, resulting in a LOD score
x6. Because the mapping services did not provide as-
signments for markers D2S114 and D2S442 or the dis-
tance between them, the RHMAP statistical package for
RH mapping (Cox et al. 1990; Boehnke et al. 1991) also
was used.
Physical Mapping
The initial YAC contigs were assembled by CEPH/
Ge´ne´thon. YAC clones previously assigned to chromo-
some 2q were ordered from the Sanger Centre (Medical
Research Council, United Kingdom). The presence of the
known markers of the CLD locus and three primer pairs
designed from exons 1, 8, and 17 (SHGC-10723) of the
LPH cDNA (Mantei et al. 1988) were tested by PCR
amplification. Similarly, a P1-derived artificial chromo-
some (PAC) library on 321 multiwell microtitration
plates (kindly provided by Prof. Peter de Jong, Roswell
Park Cancer Institute; Ioannou et al. 1994) was screened
for the presence of the LPH gene and the five closest
markers, D2S114, D2S442, AFMA338YE5, D2S314,
and D2S2385. The PCR-positive clones were picked up
and cultured in Luria broth supplemented with 25 mg
kanamycin/ml, and DNA was extracted from these cul-
tures, in accordance with the standard alkaline-lysis
method (Sambrook et al. 1989). The PCR conditions
were similar to those used in family studies and are de-
scribed above.
Results
Distribution of CLD in the Finnish Population
The distribution of birthplaces of the great-grandpar-
ents of 31 Finnish CLD families shows that the CLD
mutation is enriched in sparsely populated eastern and
northern Finland (fig. 2), which was inhabited during
the late settlement after the 16th century (Nevanlinna
1972; Norio et al. 1973).
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Figure 3 All CLD haplotypes and numbers of observations of
the 38 recent disease chromosomes. The ancestral founder haplotype
is shaded, and its identifiable tracers are boxed. On the basis of an-
cestral recombinations, the CLD locus could be restricted to between
markers D2S314 and D2S2385. The proportion of excess of a certain
allele, in the disease chromosomes, is expressed by the l value, which
measures the linkage disequilibrium between each marker and the
disease gene.
Table 1
Two-Point LOD Scores and Allelic Association Analyses for the
Finnish CLD Families
MARKER
LOD SCORE AT
RECOMBINATION FRACTION OF
P VALUE.0 .1 .2 .3 .4
D2S114  2.695 2.144 1.2115 .3633 7 # 107
D2S1334 7.4111 5.2754 3.3366 1.6836 .4723 .006
D2S2196 4.9193 3.6076 2.3636 1.2583 .382 .001
D2S442 4.5603 3.2086 1.9951 .9856 .2706 .00001
D2S314 7.5608 5.5431 3.6256 1.9089 .5666 9 # 1011
D2S2385 7.9287 5.86 3.8469 2.0251 .5999 3 # 1012
D2S2288 4.629 3.3637 2.1511 1.0894 .3056 .028
D2S397 6.3058 4.6755 3.075 1.6085 .4669 .000001
D2S150  4.9699 3.391 1.8271 .5486 7 # 107
D2S132  1.878 1.4583 .7909 .2282 .5
Linkage Analyses
The segregation of a total of 10 highly informative
microsatellite markers covering 9 cM flanking the LPH
gene was analyzed in 19 CLD families. The LOD scores
obtained from pairwise linkage analyses between CLD
and markers on 2q21 are given in table 1. The highest
LOD score, 7.93, was obtained with marker D2S2385.
The LOD scores significant for linkage were also
observed with seven markers, D2S1334, D2S2196,
D2S442, D2S314, D2S397, D2S2288, and D2S150.
Obligatory recombination events (both occurring in
family 5) were detected with marker D2S114, which
defines the centromeric boundary of the CLD locus, and
D2S150, which defines the corresponding telomeric
boundary of the CLD locus (table 1). Marker
AFMA338YE5 was not polymorphic in our family ma-
terial and was not included in the linkage analyses.
Ancient-Haplotype and Linkage-Disequilibrium
Analysis
Figure 3 shows all 19 extended haplotypes formed by
the seven linked markers spanning ∼6 cM. The order of
the markers was confirmed by RH mapping using the
TNG RH panel (fig. 4) and by physical mapping using
YACs assigned to this chromosomal region (fig. 5). The
mutual order of D2S1334 and D2S2196 remained un-
known. From 38 recent CLD chromosomes, 19 different
haplotypes could be formed with seven microsatellite
markers linked to the CLD gene. The suggested founder
haplotype, cen-6-4-4-2-2-3-5-tel, was present in 13
(34%) of the disease chromosomes. The other haplo-
types were separated from this putative founder hap-
lotype by ancient recombination events. These ancient
recombinations restricted the CLD locus to between
markers D2S314 and D2S2385, within a 2-cM region.
A single core haplotype, 2-2, formed by these markers
was present on 82% (31/38) of the affected chromo-
somes and on none of the unaffected chromosomes. Al-
lele 2 of D2S314 was present on 82% (31/38) of the
affected chromosomes and on 6% (2/38) of the unaf-
fected chromosomes. Allele 2 of D2S2385 was present
on 92% (35/38) of the affected chromosomes and on
6% (2/38) of the unaffected chromosomes. Three par-
ents (8% of all parents), from families 14, 19, and 21,
carried allele 7 at D2S2385, and one parent from family
5 carried allele 1 at this locus. A total of seven markers,
spanning an area 18 cM, were in linkage disequilibrium
( ) with the disease locus (table 1). The P andP X .001
l values resulting from the HRRLAMB program are
shown in table 1 and figure 3, respectively. Data from
all markers were combined by multipoint association
analysis using the HRRMULT program (Terwilliger
1995, 1996). The likelihood curve peaked between
markers D2S314 and D2S2385, with a maximum mul-
tipoint LOD score of 39.9, thus confirming the position
of the CLD gene (fig. 6). The estimated a value was
1.00, indicating locus homogeneity.
RH Mapping
The SHGC mapping service was able to localize 5 of
the 7 markers screened with the TNG panel of the SHGC
G3 map of chromosome 2: LPH exons 1 and 17 (SHGC-
10723) and marker AFMA338YE5 are linked to marker
SHGC-30722; D2S314 is linked to marker SHGC-1625;
and D2S2385 is linked to marker SHGC-20039. Thus,
the marker order is as follows: cen-LPH-AFM338YE5-
D2S314-D2S2385-tel. Analysis by means of the
RHMAP statistical package resulted in the same marker
order. On the RH map, the LPH gene was located be-
tween markers D2S114 and D2S442 (fig. 4). The dis-
tance between markers D2S314 and D2S2385, which
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Figure 4 Graphic representation of RH-mapping results from
the TNG panel. The LPH gene is shown to be located outside the
critical CLD region on 2q21 (when 1 kb is assumed; “50,000”cR ≈ 7.5
is the x-ray dose used for the construction of the panel).
restricted the CLD locus, was calculated to be 112 cR,
corresponding to ∼840 kb (when an average relation of
1 kb is assumed). On the basis of the RH-cR ≈ 7.5
mapping data, the LPH gene was localized to 265 cR
(∼2 Mb) centromeric to D2S314 (fig. 4). The marker
closest to the LPH gene, D2S442, was localized to 100
cR (∼750 kb) centromeric to D2S314.
Physical Map of the CLD Region and Location of the
LPH Gene
Figure 5 illustrates the genomic clones over the CLD
critical region and their orientation to each other. A YAC
contig was constructed with eight closely linked markers
(D2S150, D2S397, D2S2288, D2S2385, D2S314,
D2S442, D2S2196, and D2S1334), one uninformative
CA repeat marker, AFMA338YE5, and the LPH gene
and was extended ∼4.5 Mb. The presence of LPH was
analyzed by PCR amplification using three different
primer pairs, covering exons 1, 8, and 17 (SHGC-10723)
of the LPH cDNA (Mantei et al. 1988). Primers detecting
exons 1 and 8 of the LPH cDNA were positive with
YAC 944H9, which also contained markers D2S442 and
D2S314. The primers covering exons 1, 8, and 17
(SHGC-10723) of the LPH cDNA were positive with
YAC 743C2, which also contained two centromeric mi-
crosatellite markers, D2S2196 and D2S1334. An un-
informative CA-repeat marker, AFMA338YE5, was pos-
itive with PACs 69K1, 71E19, and 93I13 and with YACs
743C2 and 944H9. Consequently, the LPH gene was
assigned unequivocally to the centromeric end of YAC
944H9, between markers D2S442 and D2S2196/
D2S1334, and definitively outside the core haplotype.
Three YACs (850D5, 948D3, and 775E6) contained
both of the closest markers, D2S314 and D2S2385. Two
of these YACs (850D5 and 948D3) also were positive
for markers D2S442 and D2S2288. On the basis of the
published size of the YACs, the LPH gene should reside
12 Mb from the closest marker, D2S2385 (fig. 5).
Discussion
We describe the refined assignment of the CLD locus
to human chromosome 2q by linkage, linkage-disequi-
librium, and ancient-haplotype analyses. We also pro-
vide evidence that a novel gene in this region causes
CLD, since we excluded the LPH gene as a causative
gene for CLD, on the basis of RH-mapping results and
the physical location of the LPH gene in the critical
chromosomal region.
Adult-type hypolactasia (MIM 223100) is the most
frequent genetic enzyme deficiency in humans. The fre-
quency varies between different populations, from
2.6%–6.6% in Danes to 100% in healthy Thais (Sahi
et al. 1972). CLD, however, is very rare. It is enriched
in the Finnish population, with a total of 32 CLD fam-
ilies diagnosed so far, whereas only 18 cases have been
reported outside Finland (Savilahti et al. 1983). The ac-
tivity of lactase and its accompanying enzyme, phlorizin
hydrolase, is reduced in adult-type hypolactasia to
5%–10% of that at birth. In 70% of CLD patients, LPH
activity is reduced more, to 0%–2% of that at birth. In
the rest of the CLD patients, LPH activity is 3%–10%
of that at birth, which overlaps with the LPH-activity
values for adult-type hypolactasia. In these borderline
cases, it might be difficult to distinguish CLD from the
more common adult-type hypolactasia. The age at onset
of adult-type hypolactasia varies between different pop-
ulations, starting at 2–4 years of age among Thais and
at school age among Caucasians. In the Finnish popu-
lation, the age at onset of adult-type hypolactasia varies
within the range 5–20 years (Sahi et al. 1972). The gas-
trointestinal symptoms of adult-type hypolactasia usu-
ally are mild or not present, whereas, without proper
treatment, CLD often would be lethal: the diarrhea is
so severe that 90% of infants remain below their birth
weight as long as they eat lactose-containing milks. All
but one affected child in this study was hospitalized as
a newborn, and the diagnosis of CLD was based on
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Figure 5 Physical map of the CLD locus on 2q21. The PAC clones are shown above the horizontal axis, and the YAC clones are shown
below it. Vertical lines indicate the microsatellites present in the clones. Old recombinations detectable in extended disease haplotypes restricted
the CLD region to between D2S314 and D2S2385 (blackened rectangle). The primers used to detect the LPH-positive PAC and YAC clones
were nt 1640–1660 and nt 1770–1751 for exon 1, nt 2540–2560 and nt 2660–2641 for exon 8, and human STS SHGC-10723 for exon 17
of the LPH cDNA (Mantei et al. 1988).
determination of lactase activity in their jejunal biopsy
specimens (Savilahti et al. 1983). One patient suffered
from continuous diarrhea and was studied at the hos-
pital at 4 mo of age, because of poor weight gain. Careful
analysis of clinical phenotype should minimize the ge-
netic heterogeneity in our family material.
The LPH gene had been assigned to 2q21 (Kruse et
al. 1988; Harvey et al. 1993), which guided us to analyze
this region as a candidate region for CLD. After ana-
lyzing 10 highly polymorphic microsatellite markers
flanking the LPH gene, we obtained significant LOD
scores with 8 of them. Seven markers, spanning an area
of 18 cM, were in strong linkage disequilibrium (P !
) with the disease locus, thus confirming the close.001
linkage. We further utilized the characteristics of the iso-
lated Finnish population by analyzing the ancient hap-
lotypes surrounding the CLD locus. Previous molecular
genetic studies of the Finnish diseases have shown that,
characteristically, one major haplotype or allele has been
enriched in disease chromosomes, reflecting one founder
mutation (Peltonen and Uusitalo 1997). In CLD, core
haplotype 2-2, formed by the closest markers to the CLD
locus, D2S314 and D2S2385, was present in 82% of
the affected chromosomes and in none of the unaffected
chromosomes. Furthermore, 92% of the affected chro-
mosomes carried a single allele 2 of the closest marker,
D2S2385, supporting the hypothesis of one major mu-
tation at the CLD locus among Finns. The genealogical
data shows that the ancestors of the three parents (8%)
carrying the more rare disease allele 7 of D2S2385 were
born in three neighboring villages close to the border
between Russia and Finland. This allele might represent
another, minor mutation underlying CLD. One parent
carried allele 1 at this locus. This could be explained by
a microsatellite mutation event or by a potential third
mutation underlying CLD (fig. 3).
The order of the analyzed markers was defined by the
TNG RH-mapping panel of the SHGC G3 map of chro-
mosome 2 and by the RHMAP statistical package (Cox
et al. 1990; Boehnke et al. 1991). The distance between
critical markers D2S314 and D2S2385 was estimated to
be ∼840 kb. The LPH gene was found to be positioned
between D2S114 and D2S442, by use of two different
markers (primers of exons 1 and 17 [SHGC-10723]) of
the LPH gene and marker AFMA338YE5, which was
positive with LPH-containing PACs; also, the LPH gene
is located 12 Mb centromeric to D2S314, outside the
critical region.
The physical location of the LPH gene also was de-
termined by sequence-tagged–site (STS) mapping of
chromosomes 2q21–specific YACs. The LPH gene was
positioned centromeric to marker D2S442, which shows
a genetic distance of ∼2 cM from marker D2S314. This
distance was supported by the RH-mapping data. In
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Figure 6 Multipoint likelihood-ratio statistic for the CLD gene. The graph shows the most likely location of the CLD gene, relative to
the known fixed positions of the marker loci.
addition, on the basis of the size of the YACs, the cor-
responding physical distance was determined to be 12
Mb from marker D2S2385, closest to the hypothetical
CLD locus. The close proximity of LPH to markers
D2S2385 and D2S314 was excluded further by STS
mapping of PACs: all three LPH-positive PACs (69K1,
71E19, and 93I13) were negative with these markers.
Thus, both genetic and physical data prove unequivo-
cally that the LPH gene lies outside the ancient core
haplotype 2-2 and, consequently, can be excluded as a
causative gene. The cDNA code and the ∼1-kb regula-
tory region of the LPH gene have been cloned and se-
quenced (Mantei et al. 1988). Mutation analysis of the
cDNA coding for the LPH gene and its promoter region
has not revealed any sequence differences in the cDNA
either of one of our Finnish CLD patients (Poggi and
Sebastio 1991) or of patients with adult-type hypolac-
tasia (Boll et al. 1991), which further supports our
conclusion.
The results of the genealogical study showed that the
majority of the ancestors of CLD patients was concen-
trated in the sparsely populated areas of eastern and
northern Finland, which were inhabited during and after
the internal migration movement in the 16th century
(Norio et al. 1973). This is compatible with the ob-
served, relatively wide linkage-disequilibrium interval of
18 cM. The geographic distribution and the extent of
linkage disequilibrium of CLD indicate a young muta-
tion, the history of which closely resembles that of in-
fantile cerebellar ataxia, which has been estimated to
have been introduced into the Finnish population 30–40
generations ago (infantile onset spinal cerebellar ataxia;
Nikali et al. 1994; Varilo et al. 1996a). If the CLD mu-
tation was enriched during the same period ( ),n  30
the CLD gene should lie ∼350 kb (total range 0–1,580
kb) from the closest marker, D2S2385, according to the
linkage-disequilibrium analysis (Terwilliger 1995; Varilo
et al. 1996b).
The assignment of the CLD locus to chromosome
2q21 will facilitate the identification of the novel gene
underlying the congenital form of lactase deficiency.
Moreover, it will provide new tools that can be used to
analyze potential similarities to the pathogenesis/molec-
ular genetics of adult-type hypolactasia.
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